Skip to content

Effect of esketamine combined with remimazolam on postoperative sleep quality in gynecologic surgery patients

Effect of esketamine combined with remimazolam on postoperative sleep quality in gynecologic surgery patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129327
Enrollment
Unknown
Registered
2026-08-03
Start date
2026-08-15
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sleep disorder

Interventions

Esketamine group:Esketamine
Remimazolam group:Remimazolam
The remimazolam combined with esketamine group:remimazolam combined with esketamine
Propofol group:Propofol

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective gynecological surgery under general anesthesia; 2.Aged over 18 years; 3.ASA physical status ?–?; 4.BMI 18.5–27.9 kg/m^2;

Exclusion criteria

Exclusion criteria: 1. Patients refuse to participate in the study; 2. Preoperative Pittsburgh Sleep Quality Index (PSQI) 7; 3. Recent history of substance abuse or drug addiction; 4.Contraindications or allergy to esketamine and remimazolam; 5.Cognitive dysfunction or inability to communicate.

Design outcomes

Primary

MeasureTime frame
Athens Insomnia Scale,AIS;Pittsburgh Sleep Quality Index (PSQI);

Secondary

MeasureTime frame
intraoperative dosage of vasoactive drugs;perioperative consumption of opioids;perioperative adverse reactions;intraoperative hemodynamic changes;Visual Analogue Scale (VAS);

Countries

China

Contacts

Public ContactGuanglei Wang

The Affiliated Hospital of Xuzhou Medical University

13852087156@163.com+86 516 85802297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026